Sterile Vials Market

Sterile Vials Market (Product: Sterile Empty Vial, Sterile Liquid Filled Vial, and Individual Sterilized Components [ISCs]; Volume: <2ml, 2 ml to 5 ml, 5 ml to 10 ml, 10 ml to 20 ml, and >20ml; Material: Glass and Plastic; and End User: Clinical Labs, Compounding Labs, Biopharmaceutical Companies, CMOs, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Manufacturers May Profit from Packaging of COVID-19 Vaccines

Since pharmaceutical companies have entered the competition to manufacture COVID-19 vaccines, there has been an unprecedented demand for sterile vials. Manufacturers in the sterile vials market are taking advantage of this opportunity and are working at break-neck speeds to maintain robust supply chains. Stevanato Group - a provider of integrated containment and delivery solutions for the biopharmaceutical industry, has amped up its production of sterile vials for COVID-19 vaccines.

Since an increasing number of patients and individuals has been stocking medical supplies, owing to uncertainty during coronavirus curfews and lockdowns, manufacturers in the sterile vials market have been able to stay afloat during the peak pandemic period. Such manufacturers are anticipated to stay in the business during Q2 and Q3 of FY2021 due to reported COVID-19 infection in individuals amidst the gap between first and second dose of a vaccine.

sterile vials market segmentation

Hybrid Packaging Solutions Help Meet Global Demand for COVID-19 Sterile Vials

While pharmaceutical companies are highly focused on coronavirus vaccine development, they are also considering primary packaging alternatives to fill, store, and distribute billions of vaccine doses worldwide. However, pharma companies are facing a global shortage of borosilicate glass due to unexpected and unprecedented demand for sterile vials. On the other hand, ordinary plastics increase risk of compromising drug efficacy and stability. Hence, companies in the sterile vials market are increasing their research in hybrid packaging solutions involving SiO2 (Silica) Materials Science that combines glass and plastic without their respective drawbacks.

Companies Collaborate with Highest Quality Machine Suppliers to Achieve Vial Sterility

The sterile vials market is predicted to expand at a favorable CAGR of ~8% during the assessment period. Manufacturers are collaborating with the highest quality machine suppliers to achieve vial sterility until the filling area, avoid contamination, and match filling technology standards. SGD Pharma is gaining popularity for supplying sterile vials produced and controlled in severe conditions to guarantee patient safety and protect the physical integrity of the vials.

Companies in the sterile vials market are increasing the availability of high quality sterile and depyrogenated molded glass vials that are gaining prominence in the pharmaceutical primary packaging industry. ISO complaint standard finish neck and strong packaging in vials is being preferred to withstand extreme conditions encountered during the lyophilization process.

Multi-layer Extrusion Blow Molding Technology in Vials Offers Robust Moisture Barrier

Innovative pharmaceutical packaging solutions for oral liquids pertaining to human health and sterile injectables for animal health are translating into revenue opportunities for companies in the sterile vials market. Honeywell International Inc. - the U.S. publicly traded multinational conglomerate, has announced its Aclar Edge pharmaceutical packaging solution made using their proprietary multi-layer extrusion blow molding technology. Manufacturers are taking cues from such innovations to adopt technologies that improve user safety during handling and administration.

Novel sterile vials and bottles help to preserve the shelf life of oral liquids and sterile injectables for a large variety of challenging applications. Manufacturers in the sterile vials market are bolstering their output capacities in containers that perform robust moisture barrier and enhanced oxygen barrier as compared to polymeric containers.

Leak-proof Cryopreservation Vials Comply with Contaminant-free Workflows

Companies in the sterile vials market are expanding their revenue streams in cryopreservation tubes. Maxxline® is being highly publicized as a high-quality Danish brand, delivering exceptional sterile cryovials to provide contamination-free sample collection systems. Companies are increasing efforts to provide sterility assurance for each cryopreservation tube in order to adhere with contaminant-free workflows.

Manufacturers in the sterile vials market are producing cryopreservation vials and packaging, which is free from detectable heavy metal contamination. In order to boost their credibility in the competitive market landscape, manufacturers are conducting quality checks against cytotoxic substances and any detectable RNases/DNases. As such, there is a growing demand for leak-proof sterile cryopreservation vials of external thread designs that reduce the risk of contamination without adding bulk to the cryopreservation tube.

sterile vials market infographic

Analysts’ Viewpoint

The ever-evolving nature of COVID-19 strains and reported infection in individuals amidst the gap between first and second dose of vaccine is anticipated to generate continued revenue flow, owing to the demand for sterile vials. The sterile vials market offers a value projection of US$ 12 Bn by 2031. However, breakage, cracks, and delamination are longstanding problems in lyophilization glass vials that result in an increasing number of product recalls. Hence, companies should collaborate with the highest quality machine suppliers to drive improvements in new and strong materials that protect the physical integrity of vials and prevent contamination.

Sterile Vials Market: Overview

  • According to Transparency Market Research’s latest report on the global sterile vials market for the historical period 20172019 and forecast period 20212031, strong growth of biologics and combination drug/device products across the globe, increase in global geriatric population, and rise in awareness among consumers about infections are projected  to propel the global sterile vials market during the forecast period
  • According to the report, the global sterile vials market was valued over US$ 4.6 Bn in 2020 and is anticipated to expand at a CAGR of ~8% from 2021 to 2031

High Adoption of Glass Vials Compared to Alternative Containers: Key Driver

  • Drug and pharmaceutical manufacturers need to maintain the required quality of sensitive medicines while storing and supplying. Drugs and medicines come in contact with storage containers made of aluminum and other vessels that impart some amount of flavor into the drugs, which degrades the quality. However, glass vials are non-reactive with the drug stored in them. Moreover, these glass vials are dust-resistant and easy to clean. Furthermore, features such as longer shelf life and contamination-free storage increase the popularity of glass vials.
  • Rise in inclination of various end users, such as biopharmaceutical companies, CMOs, and clinical labs, toward glass vials boosts the growth of the global sterile vials market. Moreover, glass vials are easily recyclable, and glass is considered eco-friendly material, which propels its popularity. This shift in focus of end users from conventional containers and vials to glass vials propels the global sterile vials market.

Capital Investment by Leading Manufacturers in Pharmaceutical Packaging Sector Boosts Market Growth

  • Rapid expansion of the global healthcare industry fuels the growth of the global sterile vials market. Increase in demand for pharmaceutical products across the world is expected to create significant opportunities for pharmaceutical packaging manufacturers during the forecast period. Leading manufacturers invest in sterile vials to consolidate their position in the global market.
    • For instance, in June 2020, Corning, Inc. received US$ 204 Mn in funding to expand domestic manufacturing capacity of Corning Valor Glass vials to support the vaccination and treatment of billions of patients under White House’s Operation Warp Speed Initiative
    • Consistent capital investment by prominent sterile vials manufacturers to expand global business provides various opportunities in the global sterile vials market. Furthermore, various initiatives by governments to improve health care facilities in underdeveloped regions augments the global sterile vials market.

Presence of Counterfeit Products to Hamper Global Market

  • Products supplied in the counterfeit market directly and indirectly affect the revenue of the pharmaceuticals as well as associated markets. Supply of counterfeit pharmaceutical products that imitate authentic drugs result in loss of capital invested in packaging, design trademarks, intellectual property rights, etc.
  • The global sterile vials market suffers loss of business and market opportunities due to the presence of counterfeit pharmaceutical products. Packaging design and solutions are the most probable target factors, wherein counterfeiters try to imitate authentic products.
  • Manufacturers who design and produce packaging solutions, which are easier to imitate, are affected by counterfeiting activities in Western Europe. Counterfeiting through packaging is primarily targeted through secondary packaging formats. Manufacturers who fail to incorporate tamper evident and anti-counterfeit mechanisms into their secondary packaging solution give way to counterfeiters to duplicate authentic products.
  • Hence, counterfeit products in the global sterile vials market affect the revenue of the market segments. These factors are likely to hamper the growth of the global sterile vials market during the forecast period.

Sterile Vials Market: Competition Landscape

  • This report profiles major players in the global sterile vials market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
  • Leading players operating in the global sterile vials market are
    • Adelphi Healthcare Packaging
    • APG Europe
    • Bormioli Pharma S.p.a.
    • Corning Incorporated
    • Dalton Pharma Services
    • DWK Life Sciences GmbH
    • Gerresheimer AG
    • Nipro Corporation
    • O.Berk Company
    • Pacific Vial
    • Piramal Glass (Piramal Enterprises Ltd.)
    • Schott AG
    • SDG Pharma
    • Shandong Pharmaceutical Glass Co. Ltd.
    • SiO2 Materials Science
    • Stevanato Group
    • Thermo Fisher Scientific, Inc.
    • West Pharmaceutical Services, Inc.

Sterile Vials Market: Key Developments

  • Key players in the global sterile vials market are engaged in regulatory approvals, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global sterile vials market. Few expansion strategies adopted by players operating in the global sterile vials market are:
    • In January 2021, Gerresheimer opened a second production plant in Kosamba (Gujarat) to strengthen the production capacity for Triveni plastic containers, which has significant demand across the world
    • In October 2020, West Pharmaceutical Services, Inc. announced FDA 510(k) clearance and the launch of New Vial2Bag Advanced 20mm Admixture Device. The Vial2Bag Advanced 20mm Admixture Device enables reconstitution and transfer of a drug between a vial and an IV bag. The innovative needle-free and easy-to-use device is ideal for immediate use and can optimize pharmacy cleanroom time, while assisting in standardizing admixture systems to maximize the efficiency of point-of-care nursing.
    • In September 2020, DWK Life Sciences announced the closing of the acquisition of Müller + Müller. Müller + Müller is a Germany-based manufacturer of primary packaging materials made of tubular glass for the pharmaceutical industry. Despite being part of the DWK Life Sciences group, Müller + Müller will continue to serve its customers under the same name and management.
    • In May 2020, Corning Incorporated and Pfizer, Inc. announced the execution of a long-term purchase and supply agreement for Corning Valor Glass. The multiyear agreement provides for the supply of Valor Glass vials to a portion of currently marketed Pfizer drug products, pending regulatory approval.
    • In October 2019, West Pharmaceutical Services, Inc., a global leader in innovative solutions for injectable drug administration, and the international technology group Schott, a leading primary packaging solutions provider announced partnership to combine the SCHOTT iQ platform with West's Ready Pack system. The collaboration will initially launch by combining West components and SCHOTT's adaptiQ high-quality RTU glass vials and will expand to include other convenient, ready-to-use combinations of West and SCHOTT products, to be available on a small-quantity basis.
    • In July 2018, Gerresheimer acquired Sensile Medical to extend its business model in the direction of original equipment manufacturer (OEM) for drug delivery platforms
  • The report on the global sterile vials market discussed individual strategies, followed by company profiles of service providers of sterile vials. The competition landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global sterile vials market.

Frequently Asked Questions

What is the total market worth of sterile vials market?

Sterile vials market was valued over US$ 4.6 Bn in 2020 and is expected to reach valuation of US$ 12 Bn by 2031

What is the anticipated CAGR of the sterile vials market in the forecast period?

Sterile vials market is anticipated to expand at a CAGR of 8% from 2021 to 2031

What are the key driving factors for the growth of the sterile vials market?

Sterile vials market is driven by increase in global geriatric population, rise in awareness among consumers about infections, and growth of biologics and combination drug/device products across the globe

Which is the rising prominent segment in the sterile vials market?

The sterile empty vial segment held major sterile vials market and the trend is projected to continue during the forecast period

Who are the key players in sterile vials market?

Key players in the global sterile vials market include Adelphi Healthcare Packaging, APG Europe, Bormioli Pharma S.p.a., Corning Incorporated, Dalton Pharma Services, DWK Life Sciences GmbH

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Sterile Vials Market

4. Market Overview

    4.1. Introduction

        4.1.1. Market Introduction

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

        4.3.4. Trends

    4.4. Global Sterile Vials Market Analysis and Forecast, 2017–2031

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections 

5. Key Insights

    5.1. Recent Development (industry updates, merger & acquisitions)

    5.2. Key Vendor and Distributor Analysis

    5.3. Sterile Vials Pricing Analysis

    5.4. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

6. Global Sterile Vials Market Analysis and Forecasts, by Product 

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value and Volume Forecast by Product, 2017–2031

        6.3.1. Sterile Empty Vial

            6.3.1.1. Sterile Evacuated Vial

            6.3.1.2. Sterile Nitrogen Filled Vial

            6.3.1.3. Sterile Air Filled Vial

        6.3.2. Sterile Liquid Filled Vial

            6.3.2.1. Sterile Saline Filled Vial

            6.3.2.2. Sterile Media Filled Vial

            6.3.2.3. Sterile Water Filled Vial

        6.3.3. Individual Sterilized Components (ISCs)

    6.4. Market Attractiveness Analysis, by Product 

7. Global Sterile Vials Market Analysis and Forecast, by Volume 

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value and Volume Forecast, by Volume, 2017–2031

        7.3.1. <2ml

        7.3.2. 2 ml to 5ml

        7.3.3. 5 ml to 10 ml

        7.3.4. 10 ml to 20 ml

        7.3.5. >20ml

    7.4. Market Attractiveness Analysis, by Volume 

8. Global Sterile Vials Market Analysis and Forecast, by Material 

    8.1. Introduction & Definition

    8.2. Key Findings / Developments

    8.3. Market Value & Volume Forecast, by Material, 2017–2031

        8.3.1. Glass

        8.3.2. Plastic

    8.4. Market Attractiveness Analysis, by Material 

9. Global Sterile Vials Market Analysis and Forecast, by End-user 

    9.1. Introduction & Definition

    9.2. Key Findings / Developments

    9.3. Market Value and Volume Forecast, by End-user, 2017–2031

        9.3.1. Clinical Labs

        9.3.2. Compounding Labs

        9.3.3. Biopharmaceutical Companies

        9.3.4. CMOs

        9.3.5. Others

    9.4. Market Attractiveness Analysis, by End-user 

10. Global Sterile Vials Market Analysis and Forecast, by Region

    10.1. Key Findings

    10.2. Market Value and Volume Forecast, by Region

        10.2.1. North America 

        10.2.2. Europe 

        10.2.3. Asia Pacific 

        10.2.4. Latin America 

        10.2.5. Middle East & Africa 

    10.3. Market Attractiveness Analysis, by Country/Region

11. North America Sterile Vials Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value and Volume Forecast, by Product, 2017–2031

        11.2.1. Sterile Empty Vial

            11.2.1.1. Sterile Evacuated Vial

            11.2.1.2. Sterile Nitrogen Filled Vial

            11.2.1.3. Sterile Air Filled Vial

        11.2.2. Sterile Liquid Filled Vial

            11.2.2.1. Sterile Saline Filled Vial

            11.2.2.2. Sterile Media Filled Vial

            11.2.2.3. Sterile Water Filled Vial

        11.2.3. Individual Sterilized Components (ISCs)

    11.3. Market Value and Volume Forecast, by Volume, 2017–2031

        11.3.1. <2ml

        11.3.2. 2 ml to 5ml

        11.3.3. 5 ml to 10 ml

        11.3.4. 10 ml to 20 ml

        11.3.5. >20ml

    11.4. Market Value & Volume Forecast, by Material, 2017–2031

        11.4.1. Glass

        11.4.2. Plastic

    11.5. Market Value and Volume Forecast, by End-user, 2017–2031

        11.5.1. Clinical Labs

        11.5.2. Compounding Labs

        11.5.3. Biopharmaceutical Companies

        11.5.4. CMOs

        11.5.5. Others

    11.6. Market Value and Volume Forecast, by Country, 2017–2031

        11.6.1. U.S.

        11.6.2. Canada

    11.7. Market Attractiveness Analysis 

        11.7.1. By Product 

        11.7.2. By Volume 

        11.7.3. By Material 

        11.7.4. By End-user 

        11.7.5. By Country

12. Europe Sterile Vials Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value and Volume Forecast, by Product, 2017–2031

        12.2.1. Sterile Empty Vial

            12.2.1.1. Sterile Evacuated Vial

            12.2.1.2. Sterile Nitrogen Filled Vial

            12.2.1.3. Sterile Air Filled Vial

        12.2.2. Sterile Liquid Filled Vial

            12.2.2.1. Sterile Saline Filled Vial

            12.2.2.2. Sterile Media Filled Vial

            12.2.2.3. Sterile Water Filled Vial

        12.2.3. Individual Sterilized Components (ISCs)

    12.3. Market Value and Volume Forecast, by Volume, 2017–2031

        12.3.1. <2ml

        12.3.2. 2 ml to 5ml

        12.3.3. 5 ml to 10 ml

        12.3.4. 10 ml to 20 ml

        12.3.5. >20ml

    12.4. Market Value & Volume Forecast, by Material, 2017–2031

        12.4.1. Glass

        12.4.2. Plastic

    12.5. Market Value and Volume Forecast, by End-user, 2017–2031

        12.5.1. Clinical Labs

        12.5.2. Compounding Labs

        12.5.3. Biopharmaceutical Companies

        12.5.4. CMOs

        12.5.5. Others

    12.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031

        12.6.1. Germany

        12.6.2. U.K.

        12.6.3. France

        12.6.4. Spain

        12.6.5. Italy

        12.6.6. Rest of Europe

    12.7. Market Attractiveness Analysis 

        12.7.1. By Product 

        12.7.2. By Volume 

        12.7.3. By Material 

        12.7.4. By End-user 

        12.7.5. By Country/Sub-region

13. Asia Pacific Sterile Vials Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value and Volume Forecast, by Product, 2017–2031

        13.2.1. Sterile Empty Vial

            13.2.1.1. Sterile Evacuated Vial

            13.2.1.2. Sterile Nitrogen Filled Vial

            13.2.1.3. Sterile Air Filled Vial

        13.2.2. Sterile Liquid Filled Vial

            13.2.2.1. Sterile Saline Filled Vial

            13.2.2.2. Sterile Media Filled Vial

            13.2.2.3. Sterile Water Filled Vial

        13.2.3. Individual Sterilized Components (ISCs)

    13.3. Market Value and Volume Forecast, by Volume, 2017–2031

        13.3.1. <2ml

        13.3.2. 2 ml to 5ml

        13.3.3. 5 ml to 10 ml

        13.3.4. 10 ml to 20 ml

        13.3.5. >20ml

    13.4. Market Value & Volume Forecast, by Material, 2017–2031

        13.4.1. Glass

        13.4.2. Plastic

    13.5. Market Value and Volume Forecast, by End-user, 2017–2031

        13.5.1. Clinical Labs

        13.5.2. Compounding Labs

        13.5.3. Biopharmaceutical Companies

        13.5.4. CMOs

        13.5.5. Others

    13.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031

        13.6.1. China

        13.6.2. Japan

        13.6.3. India

        13.6.4. Australia & New Zealand

        13.6.5. Rest of Asia Pacific

    13.7. Market Attractiveness Analysis 

        13.7.1. By Product 

        13.7.2. By Volume 

        13.7.3. By Material 

        13.7.4. By End-user 

        13.7.5. By Country/Sub-region

14. Latin America Sterile Vials Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Market Value and Volume Forecast, by Product, 2017–2031

        14.2.1. Sterile Empty Vial

            14.2.1.1. Sterile Evacuated Vial

            14.2.1.2. Sterile Nitrogen Filled Vial

            14.2.1.3. Sterile Air Filled Vial

        14.2.2. Sterile Liquid Filled Vial

            14.2.2.1. Sterile Saline Filled Vial

            14.2.2.2. Sterile Media Filled Vial

            14.2.2.3. Sterile Water Filled Vial

        14.2.3. Individual Sterilized Components (ISCs)

    14.3. Market Value and Volume Forecast, by Volume, 2017–2031

        14.3.1. <2ml

        14.3.2. 2 ml to 5ml

        14.3.3. 5 ml to 10 ml

        14.3.4. 10 ml to 20 ml

        14.3.5. >20ml

    14.4. Market Value & Volume Forecast, by Material, 2017–2031

        14.4.1. Glass

        14.4.2. Plastic

    14.5. Market Value and Volume Forecast, by End-user, 2017–2031

        14.5.1. Clinical Labs

        14.5.2. Compounding Labs

        14.5.3. Biopharmaceutical Companies

        14.5.4. CMOs

        14.5.5. Others

    14.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031

        14.6.1. Brazil

        14.6.2. Mexico

        14.6.3. Rest of Latin America

    14.7. Market Attractiveness Analysis 

        14.7.1. By Product 

        14.7.2. By Volume 

        14.7.3. By Material 

        14.7.4. By End-user 

        14.7.5. By Country/Sub-region

15. Middle East & Africa Sterile Vials Market Analysis and Forecast

    15.1. Introduction

        15.1.1. Key Findings

    15.2. Market Value and Volume Forecast, by Product, 2017–2031

        15.2.1. Sterile Empty Vial

            15.2.1.1. Sterile Evacuated Vial

            15.2.1.2. Sterile Nitrogen Filled Vial

            15.2.1.3. Sterile Air Filled Vial

        15.2.2. Sterile Liquid Filled Vial

            15.2.2.1. Sterile Saline Filled Vial

            15.2.2.2. Sterile Media Filled Vial

            15.2.2.3. Sterile Water Filled Vial

        15.2.3. Individual Sterilized Components (ISCs)

    15.3. Market Value and Volume Forecast, by Volume, 2017–2031

        15.3.1. <2ml

        15.3.2. 2 ml to 5ml

        15.3.3. 5 ml to 10 ml

        15.3.4. 10 ml to 20ml

        15.3.5. >20ml

    15.4. Market Value & Volume Forecast, by Material, 2017–2031

        15.4.1. Glass

        15.4.2. Plastic

    15.5. Market Value and Volume Forecast, by End-user, 2017–2031

        15.5.1. Clinical Labs

        15.5.2. Compounding Labs

        15.5.3. Biopharmaceutical Companies

        15.5.4. CMOs

        15.5.5. Others

    15.6. Market Value and Volume Forecast, by Country/Sub-region, 2017–2031

        15.6.1. GCC Countries

        15.6.2. South Africa

        15.6.3. Rest of Middle East & Africa

    15.7. Market Attractiveness Analysis 

        15.7.1. By Product 

        15.7.2. By Volume 

        15.7.3. By Material 

        15.7.4. By End-user 

        15.7.5. By Country/Sub-region

16. Competitive Landscape

    16.1. Market Player - Competition Matrix (by tier and size of companies)

    16.2. Company Profiles

        16.2.1. Adelphi Healthcare Packaging (The Adelphi Group Of Companies)

            16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.1.2. Financial Overview

            16.2.1.3. Product Portfolio

            16.2.1.4. Strategic Overview

            16.2.1.5. SWOT Analysis

        16.2.2. APG Europe

            16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.2.2. Financial Overview

            16.2.2.3. Product Portfolio

            16.2.2.4. Strategic Overview

            16.2.2.5. SWOT Analysis

        16.2.3. Bormioli Pharma S.p.a.

            16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.3.2. Financial Overview

            16.2.3.3. Product Portfolio

            16.2.3.4. Strategic Overview

            16.2.3.5. SWOT Analysis

        16.2.4. Corning Incorporated

            16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.4.2. Financial Overview

            16.2.4.3. Product Portfolio

            16.2.4.4. Strategic Overview

            16.2.4.5. SWOT Analysis

        16.2.5. Dalton Pharma Services

            16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.5.2. Financial Overview

            16.2.5.3. Product Portfolio

            16.2.5.4. Strategic Overview

            16.2.5.5. SWOT Analysis

        16.2.6. DWK Life Sciences GmbH

            16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.6.2. Financial Overview

            16.2.6.3. Product Portfolio

            16.2.6.4. Strategic Overview

            16.2.6.5. SWOT Analysis

        16.2.7. Gerresheimer AG

            16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.7.2. Financial Overview

            16.2.7.3. Product Portfolio

            16.2.7.4. Strategic Overview

            16.2.7.5. SWOT Analysis

        16.2.8. Nipro Corporation

            16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.8.2. Financial Overview

            16.2.8.3. Product Portfolio

            16.2.8.4. Strategic Overview

            16.2.8.5. SWOT Analysis

        16.2.9. O.Berk Company

            16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.9.2. Financial Overview

            16.2.9.3. Product Portfolio

            16.2.9.4. Strategic Overview

            16.2.9.5. SWOT Analysis 

        16.2.10. Pacific Vial

            16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.10.2. Financial Overview

            16.2.10.3. Product Portfolio

            16.2.10.4. Strategic Overview

            16.2.10.5. SWOT Analysis

        16.2.11. Piramal Glass (Piramal Enterprises Ltd.)

            16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.11.2. Financial Overview

            16.2.11.3. Product Portfolio

            16.2.11.4. Strategic Overview

            16.2.11.5. SWOT Analysis

        16.2.12. Schott AG

            16.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.12.2. Financial Overview

            16.2.12.3. Product Portfolio

            16.2.12.4. Strategic Overview

            16.2.12.5. SWOT Analysis

        16.2.13. SDG Pharma

            16.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.13.2. Financial Overview

            16.2.13.3. Product Portfolio

            16.2.13.4. Strategic Overview

            16.2.13.5. SWOT Analysis

        16.2.14. Shandong Pharmaceutical Glass Co. Ltd.

            16.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.14.2. Financial Overview

            16.2.14.3. Product Portfolio

            16.2.14.4. Strategic Overview

            16.2.14.5. SWOT Analysis

        16.2.15. SiO2 Materials Science

            16.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.15.2. Financial Overview

            16.2.15.3. Product Portfolio

            16.2.15.4. Strategic Overview

            16.2.15.5. SWOT Analysis

        16.2.16. Stevanato Group

            16.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.16.2. Financial Overview

            16.2.16.3. Product Portfolio

            16.2.16.4. Strategic Overview

            16.2.16.5. SWOT Analysis

        16.2.17. Thermo Fisher Scientific, Inc.

            16.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.17.2. Financial Overview

            16.2.17.3. Product Portfolio

            16.2.17.4. Strategic Overview

            16.2.17.5. SWOT Analysis

        16.2.18. West Pharmaceutical Services, Inc.

            16.2.18.1. Company Overview (HQ, Business Segments, Employee Strength)

            16.2.18.2. Financial Overview

            16.2.18.3. Product Portfolio

            16.2.18.4. Strategic Overview

            16.2.18.5. SWOT Analysis

List of Tables

Table 01: Global Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 02: Global Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031

Table 03: Global Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 04: Global Sterile Vials Market Volume (Million Units) Forecast, by Product, 2017-2031

Table 05: Global Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031

Table 06: Global Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 07: Global Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031

Table 08: Global Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031

Table 09: Global Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031

Table 10: Global Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031

Table 11: Global Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 12: Global Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031

Table 13: Global Sterile Vials Market Value (US$ Mn) Forecast, by Region, 2017-2031

Table 14: Global Sterile Vials Market Volume (Million Units) Forecast, by Region, 2017-2031

Table 15: North America Sterile Vials Market Value (US$ Mn) Forecast, by Country, 2017-2031

Table 16: North America Sterile Vials Market Volume (Million Units) Forecast, by Country, 2017-2031

Table 17: North America Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 18: North America Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031

Table 19: North America Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 20: North America Sterile Vials Market Volume(Million Units) Forecast, by Product, 2017-2031

Table 21: North America Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031

Table 22: North America Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 23: North America Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031

Table 24: North America Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031

Table 25: North America Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031

Table 26: North America Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031

Table 27: North America Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 28: North America Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031

Table 29: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 30: Europe Sterile Vials Market Volume (Million Units) Forecast, by Country/Sub-region, 2017-2031

Table 31: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 32: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031

Table 33: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 34: Europe Sterile Vials Market Volume(Million Units) Forecast, by Product, 2017-2031

Table 35: Europe Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031

Table 36: Europe Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 37: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031

Table 38: Europe Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031

Table 39: Europe Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031

Table 40: Europe Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031

Table 41: Europe Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 42: Europe Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031

Table 43: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 44: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Country/Sub-region, 2017-2031

Table 45: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 46: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031

Table 47: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 48: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031

Table 49: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 50: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031

Table 51: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031

Table 52: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031

Table 53: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031

Table 54: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 55: Asia Pacific Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031

Table 56: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 57: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Country, 2017-2031

Table 58: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 59: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031

Table 60: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 61: Latin America Sterile Vials Market Volume(Million Units) Forecast, by Product, 2017-2031

Table 62: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031

Table 63: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 64: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031

Table 65: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031

Table 66: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031

Table 67: Latin America Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031

Table 68: Latin America Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 69: Latin America Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031

Table 70: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

Table 71: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Country/Sub-region, 2017-2031

Table 72: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Product, 2017-2031

Table 73: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Empty Vial, 2017-2031

Table 74: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 75: Middle East & Africa Sterile Vials Market Volume(Million Units) Forecast, by Product, 2017-2031

Table 76: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Sterile Empty Vial, 2017-2031

Table 77: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Sterile Liquid Filled Vial, 2017-2031

Table 78: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Volume, 2017-2031

Table 79: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Volume, 2017-2031

Table 80: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by Material, 2017-2031

Table 81: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by Material, 2017-2031

Table 82: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast, by End-user, 2017-2031

Table 83: Middle East & Africa Sterile Vials Market Volume (Million Units) Forecast, by End-user, 2017-2031

List of Figures

Figure 01: Global Sterile Vials Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Sterile Vials Market Value Share, by Product, 2020

Figure 03: Global Sterile Vials Market Value Share, by Volume, 2020

Figure 04: Global Sterile Vials Market Value Share, by Region, 2020

Figure 05: Global Sterile Vials Market Value Share, by Material, 2020

Figure 06: Global Sterile Vials Market Value Share, by End-user, 2020

Figure 07: Global Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031

Figure 08: Global Sterile Vials Market Attractiveness Analysis, by Product, 2021–2031

Figure 09: Global Sterile Vials Market Value (US$ Mn), by Sterile Empty Vial, 2017-2031

Figure 10: Global Sterile Vials Market Value (US$ Mn), by Sterile Liquid Filled Vial, 2017-2031

Figure 11: Global Sterile Vials Market Value (US$ Mn), by Individual Sterilized Components (ISCs), 2017-2031

Figure 12: Global Sterile Vials Market Value Share Analysis, by Volume, 2020 and 2031

Figure 13: Global Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031

Figure 14: Global Sterile Vials Market Value (US$ Mn), by <2ml, 2017-2031

Figure 15: Global Sterile Vials Market Value (US$ Mn), by 2 ml to 5 ml, 2017-2031

Figure 16: Global Sterile Vials Market Value (US$ Mn), by 5 to 10 ml, 2017-2031

Figure 17: Global Sterile Vials Market Value (US$ Mn), by 10 to 20 ml, 2017-2031

Figure 18: Global Sterile Vials Market Value (US$ Mn), by >20ml, 2017-2031

Figure 19: Global Sterile Vials Market Value Share Analysis, by Material, 2020 and 2031

Figure 20: Global Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031

Figure 21: Global Sterile Vials Market Value (US$ Mn), by Glass, 2017-2031

Figure 22: Global Sterile Vials Market Value (US$ Mn), by Plastic, 2017-2031

Figure 23: Global Sterile Vials Market Value Share Analysis, by End-user, 2020 and 2031

Figure 24: Global Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031

Figure 25: Global Sterile Vials Market Value (US$ Mn), by Clinical Labs, 2017-2031

Figure 26: Global Sterile Vials Market Value (US$ Mn), by Compounding Labs, 2017-2031

Figure 27: Global Sterile Vials Market Value (US$ Mn), by Biopharmaceutical Companies, 2017-2031

Figure 28: Global Sterile Vials Market Value (US$ Mn), by CMOs, 2017-2031

Figure 29: Global Sterile Vials Market Value (US$ Mn), by Others, 2017-2031

Figure 30: Global Sterile Vials Market Value Share Analysis, by Region, 2020 and 2031

Figure 31: Global Sterile Vials Market Attractiveness Analysis, by Region, 2021–2031

Figure 32: North America Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 33: North America Sterile Vials Market Value Share, by Country, 2020–2031

Figure 34: North America Sterile Vials Market Attractiveness Analysis, by Country, 2020–2031

Figure 35: North America Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031

Figure 36: North America Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031

Figure 37: North America Sterile Vials Market Value Share (%), by Volume, 2020 and 2031

Figure 38: North America Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031

Figure 39: North America Sterile Vials Market Value Share (%), by Material, 2020 and 2031

Figure 40: North America Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031

Figure 41: North America Sterile Vials Market Value Share (%), by End-user, 2020 and 2031

Figure 42: North America Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031

Figure 43: Europe Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 44: Europe Sterile Vials Market Value Share, by Country/Sub-region, 2020–2031

Figure 45: Europe Sterile Vials Market Attractiveness Analysis, by Country/Sub-region, 2020–2031

Figure 46: Europe Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031

Figure 47: Europe Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031

Figure 48: Europe Sterile Vials Market Value Share (%), by Volume, 2020 and 2031

Figure 49: Europe Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031

Figure 50: Europe Sterile Vials Market Value Share (%), by Material, 2020 and 2031

Figure 51: Europe Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031

Figure 52: Europe Sterile Vials Market Value Share (%), by End-user, 2020 and 2031

Figure 53: Europe Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031

Figure 54: Asia Pacific Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 55: Asia Pacific Sterile Vials Market Value Share, by Country/Sub-region, 2020–2031

Figure 56: Asia Pacific Sterile Vials Market Attractiveness Analysis, by Country/Sub-region, 2020–2031

Figure 57: Asia Pacific Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031

Figure 58: Asia Pacific Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031

Figure 59: Asia Pacific Sterile Vials Market Value Share (%), by Volume, 2020 and 2031

Figure 60: Asia Pacific Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031

Figure 61: Asia Pacific Sterile Vials Market Value Share (%), by Material, 2020 and 2031

Figure 62: Asia Pacific Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031

Figure 63: Asia Pacific Sterile Vials Market Value Share (%), by End-user, 2020 and 2031

Figure 64: Asia Pacific Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031

Figure 65: Latin America Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 66: Latin America Sterile Vials Market Value Share, by Country/Sub-region, 2020–2031

Figure 67: Latin America Sterile Vials Market Attractiveness Analysis, by Country/Sub-region, 2020–2031

Figure 68: Latin America Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031

Figure 69: Latin America Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031

Figure 70: Latin America Sterile Vials Market Value Share (%), by Volume, 2020 and 2031

Figure 71: Latin America Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031

Figure 72: Latin America Sterile Vials Market Value Share (%), by Material, 2020 and 2031

Figure 73: Latin America Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031

Figure 74: Latin America Sterile Vials Market Value Share (%), by End-user, 2020 and 2031

Figure 75: Latin America Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031

Figure 76: Middle East & Africa Sterile Vials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2031

Figure 77: Middle East & Africa Sterile Vials Market Value Share, by Country/Sub-region, 2020–2031

Figure 78: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by Country/Sub-region, 2020–2031

Figure 79: Middle East & Africa Sterile Vials Market Value Share Analysis, by Product, 2020 and 2031

Figure 80: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by Product, 2020–2031

Figure 81: Middle East & Africa Sterile Vials Market Value Share (%), by Volume, 2020 and 2031

Figure 82: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by Volume, 2021–2031

Figure 83: Middle East & Africa Sterile Vials Market Value Share (%), by Material, 2020 and 2031

Figure 84: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by Material, 2021–2031

Figure 85: Middle East & Africa Sterile Vials Market Value Share (%), by End-user, 2020 and 2031

Figure 86: Middle East & Africa Sterile Vials Market Attractiveness Analysis, by End-user, 2021–2031

Copyright © Transparency Market Research, Inc. All Rights reserved